NDC 14783-072

LBel Supremacie Mains

Ensulizole, Octinoxate, And Oxybenzone

LBel Supremacie Mains is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Ventura International Ltd.,. The primary component is Ensulizole; Octinoxate; Oxybenzone.

Product ID14783-072_f9c27f44-9167-439a-a8bf-0280eabe477e
NDC14783-072
Product TypeHuman Otc Drug
Proprietary NameLBel Supremacie Mains
Generic NameEnsulizole, Octinoxate, And Oxybenzone
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2010-08-15
Marketing CategoryOTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
Application Numberpart352
Labeler NameVENTURA INTERNATIONAL LTD.,
Substance NameENSULIZOLE; OCTINOXATE; OXYBENZONE
Active Ingredient Strength3 g/100mL; g/100mL; g/100mL
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 14783-072-61

1 JAR in 1 BOX (14783-072-61) > 100 mL in 1 JAR (14783-072-62)
Marketing Start Date2010-08-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 14783-072-62 [14783007262]

LBel Supremacie Mains CREAM
Marketing CategoryOTC MONOGRAPH FINAL
Application Numberpart352
Product TypeHUMAN OTC DRUG
Marketing Start Date2010-08-15

NDC 14783-072-61 [14783007261]

LBel Supremacie Mains CREAM
Marketing CategoryOTC MONOGRAPH FINAL
Application Numberpart352
Product TypeHUMAN OTC DRUG
Marketing Start Date2010-08-15
Inactivation Date2019-10-21

Drug Details

Active Ingredients

IngredientStrength
ENSULIZOLE3 g/100mL

OpenFDA Data

SPL SET ID:2062a8d1-de1e-468c-9105-20aa01e1150f
Manufacturer
UNII

NDC Crossover Matching brand name "LBel Supremacie Mains" or generic name "Ensulizole, Octinoxate, And Oxybenzone"

NDCBrand NameGeneric Name
14783-062LBelEnsulizole, Octinoxate, and Oxybenzone
14783-072LBelEnsulizole, Octinoxate, and Oxybenzone

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.